Detalhe da pesquisa
1.
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.
N Engl J Med
; 390(6): 510-521, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324484
2.
Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.
N Engl J Med
; 388(6): 511-517, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780675
3.
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
N Engl J Med
; 385(24): 2219-2229, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879448
4.
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies.
Allergy
; 79(1): 80-92, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577841
5.
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study.
Allergy
; 79(4): 924-936, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984453
6.
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
Allergy
; 79(5): 1258-1270, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108208
7.
Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasis.
J Eur Acad Dermatol Venereol
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334243
8.
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis.
J Eur Acad Dermatol Venereol
; 38(1): 42-51, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700595
9.
Oral prednisone regulates human skin T cells in delayed-type hypersensitivity reaction elicited by diphencyprone.
Allergy
; 78(8): 2255-2265, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163280
10.
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases.
Allergy
; 78(1): 178-191, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36178084
11.
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3.
Br J Dermatol
; 188(2): 208-217, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763879
12.
Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study.
J Am Acad Dermatol
; 89(2): 235-242, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37094653
13.
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin.
J Am Acad Dermatol
; 89(2): 283-292, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054814
14.
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
Acta Derm Venereol
; 103: adv5382, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083095
15.
Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study.
J Eur Acad Dermatol Venereol
; 37(3): 549-557, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376738
16.
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE).
J Eur Acad Dermatol Venereol
; 37(7): 1366-1374, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695074
17.
Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI).
J Eur Acad Dermatol Venereol
; 37(7): 1327-1335, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854864
18.
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
J Drugs Dermatol
; 22(2): 139-147, 2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36745371
19.
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Cutan Med Surg
; 27(6): 594-600, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37571829
20.
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
J Allergy Clin Immunol
; 149(4): 1402-1412, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34678325